28.92USD-0.33%Mkt Cap: 537.86M USDP/E: 1.51Last update: 2026-05-26
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral s…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap537.86M USD
Enterprise Value439.11M USD
Revenue (TTM)299.77M USD
Gross Profit274.66M USD
Net Income (TTM)367.02M USD
Revenue/Share16.53 USD
Last Price28.92 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees172
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS7665596034
Valuation
P/E (Trailing)1.51
P/E (Forward)6.37
PEG—
EV/EBITDA3.46
EV/Revenue1.46
P/S1.80
P/B1.35
EPS (TTM)19.29
EPS (Forward)4.58
52W Range
18.1432% of range52.24
52W High52.24 USD
52W Low18.14 USD
Profitability
Gross Margin93.33%
Oper. Margin20.21%
EBITDA Margin42.36%
Profit Margin124.72%
ROE93.75%
ROA71.46%
Growth
Revenue Growth10.30%
Earnings Growth-30.20%
Cash Flow & Leverage
Operating CF75.66M USD
CapEx (TTM)—
FCF Margin26.20%
FCF Yield14.60%
Net Debt-100.96M USD
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.14
Current Ratio2.62
Quick Ratio2.20
Book Value/Sh21.64 USD
Cash/Share7.928 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 27, 2024
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)53.20 USD
Target Range38.00 USD – 81.00 USD
# Analysts5
Ownership
Shares Out.18.50M
Float15.95M
Insiders3.28%
Institutions94.26%
Short Interest
Short Ratio11.6d
Short % Float21.84%
Short % Out.21.27%
Shares Short3.94M
Short (prev mo.)3.81M
Technical
SMA 5028.60 (+1.1%)
SMA 20034.71 (-16.7%)
Beta1.20
S&P 52W Chg28.31%
Avg Vol (30d)401.88K
Avg Vol (10d)513.56K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—